Stocks to Watch: Paytm, Tata Group, Airtel, Vedanta, Suven Pharma, ONGC, and Others – News18

0
4
Stocks to Watch: Paytm, Tata Group, Airtel, Vedanta, Suven Pharma, ONGC, and Others – News18


Last Updated: March 01, 2024, 08:37 IST

Stocks to Watch on March 1

Stocks to watch: Shares of companies like Paytm, Tata Group, Airtel, Vedanta, Suven Pharma, ONGC, and others will probably be in deal with Friday’s commerce.

Stocks To Watch On March 1: Equity indices opened on a weak be aware on Thursday, however recovered and closed the day within the inexperienced in a extremely unstable session.

Paytm: Paytm and Paytm Payments Bank (PPBL) have mutually agreed to discontinue numerous inter-firm agreements.

L&T: It has commissioned its first hydrogen electrolyser on the inexperienced hydrogen plant at Hazira, Gujarat.

Tata Group shares: The Union Cabinet has accredited Rs 1.26 trillion price of investments in three semiconductor crops, together with a Tata group proposal to construct the nation’s first main chip fabrication facility at Dholera in Gujarat. It additionally cleared a separate Tata proposal for a chip meeting plant in Morigaon, Assam, and one other by CG Power in Sanand, Gujarat. The work on all three initiatives is anticipated to start within the subsequent 100 days.

CG Power And Industrial Solutions: The firm will make investments Rs 7,600 crore to arrange a semiconductor unit in Gujarat in partnership with Renesas Electronics Corp.

Auto shares: Auto shares will probably be in focus forward of February gross sales.

Bharti Airtel: Sunil Mittal has set a goal of attaining a Rs 300 common income per consumer (ARPU) by the tip of the fiscal 12 months 2024-25 (FY25), he instructed CNBC-TV18. He additionally mentioned customers is not going to pay something additional for 5G.

Vedanta: The Supreme Court on Thursday dismissed a plea by the Vedanta Group to reopen its copper smelter plant in Tamil Nadu’s Thoothukudi, citing “serious violations and repeated breaches.”

Suven Pharma: Its board has accredited the amalgamation scheme of Cohance Lifesciences with Suven, creating considered one of India’s largest built-in contract improvement and manufacturing organisation (CDMO) gamers.

Biocon: Biocon arm Biocon Biologics has signed a settlement and license settlement with Janssen Biotech Inc, and Johnson & Johnson (collectively Janssen) that clears the trail to commercialise Bmab 1200, a proposed biosimilar to Stelara within the US.

RIL, ONGC, Oil India: The authorities hiked its windfall tax on petroleum crude to Rs 4,600 per ton from Rs 3,300 with impact from March 1. Windfall tax on diesel has been reduce to zero from 1.50 per litre.

Dilip Buildcon: The firm’s unit has gained an order price Rs 1,955 crore from the NHAI.

Disclaimer:Disclaimer: The views and funding suggestions by specialists on this News18.com report are their very own and not these of the web site or its administration. Users are suggested to verify with licensed specialists earlier than taking any funding selections.



Source hyperlink